Biocartis, Microbiome to Develop Rapid Bloodstream Infection MDx | GenomeWeb

NEW YORK (GenomeWeb) – Biocartis and Microbiome recently announced a worldwide collaboration to develop an integrated multiplex, real-time PCR-based assay for the rapid detection of bloodstream infections. 

Under the terms of the deal, Microbiome's PCR assay for identifying sepsis-causing microorganisms will be further developed as an integrated multiplex, real-time PCR assay on Biocartis' Idylla platform for use in conjunction with the Belgian firm's Idylla Enrich platform, currently under development. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.